Page 2 - ஒன்றுபட்டது கிஂக்டம் மருத்துவ சுதந்திரம் கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synthetic mRNA Covid vaccines: A Risk-Benefit Analysis Published: February 23, 2021 Amidst the plethora of Covid-related issues, the Covid injections are the most imminent. Two formulations have received interim approval from the FDA, and Health Canada: Pfizer/BioNtech and Moderna. Both these injections are employing the same technology, synthetic gene therapy (SGT), which is being dispensed to the populace for the first time in human history. Medications are given to sick people to treat disease. Vaccines are given to healthy people to prevent an infection. Therefore consideration of risk-benefit analysis is paramount. Covid is the umbrella label for PCR “positive” people regardless of clinical presentation. Most are “asymptomatic,”some have generic cold/flu symptoms, and a few present with moderate or severe respiratory distress. Unfortunately, the PCR assays being used for diagnosis, are not fit for purpose. Most PCR assays are constructed based on the German Drosten

United statesUnited kingdomMecklenburg vorpommernVernon colemanHooman noorchashmDavid martinJudy mikovitsDolores cahillLou gehrigJames lyons weilerPeter doshiChris shawMichael yeadonSucharit bhakdiBoris johnsonUnited kingdom medical freedom alliance